Encephalitis - 96 Studies Found

Completed : Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
: Japanese Encephalitis
: 2013-09-26
: Biological: Japanese encephalitis chimeric vaccine (JECV) Japanese encephalitis chimeric vaccine (JECV)w
Completed : Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
: Japanese Encephalitis
: 2007-04-18
: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
Completed : A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
: Japanese Encephalitis
: 2006-04-11
:
  • Biological: ChimeriVax™-JE

Completed : Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
: Japanese Encephalitis
: 2008-01-04
:
  • Biological: Japanese Encephalitis purified inactivated vaccine (IC51)

Completed : Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
: Japanese Encephalitis
: 2008-01-04
: Biological: IC51 6 mcg, intramuscularly [i.m.], 0.5 mL
Completed : Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
: Japanese Encephalitis
: 2008-01-04
: Biological: IC51 IC51, 6 mcg, intramuscular (i.m.) booster vaccination 15 months after the primary immun
Completed : Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
: Japanese Encephalitis
: 2008-01-04
: Biological: Japanese Encephalitis purified inactivated vaccine IC51 6 mcg i.m. injection on Day 0 and Da
Completed : Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers
:
  • Japanese Encephalitis
  • Japanese Encephalit
    : 2011-07-14
    :
    • Biological: Live attenuated Japanese encephalitis chimeric virus vaccine

Active, not recruiting : Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
: Encephalitis, Tick-Borne
: 2009-04-30
: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
Completed : TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
: Encephalitis, Tick-Borne
: 2005-09-08
: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Subjects receive one vaccination with ei
<<< Previous | Next >>>